ClinicalTrials.gov
ClinicalTrials.gov Menu

AcrySof Toric Clinical Results

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01214863
Recruitment Status : Completed
First Posted : October 5, 2010
Last Update Posted : October 1, 2012
Sponsor:
Information provided by (Responsible Party):
Alcon Research

Brief Summary:
This study is an evaluation of visual outcomes of subjects implanted with the AcrySof Toric Intraocular Lenses (IOLs) Models SN60T3, SN60T4, and SN60T5.

Condition or disease Intervention/treatment
Cataracts Astigmatism Device: T3 Device: T4 Device: T5

Study Type : Observational
Actual Enrollment : 144 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Clinical Results With the AcrySof Toric Intraocular Lens (IOL)
Study Start Date : August 2007
Actual Primary Completion Date : April 2008

Group/Cohort Intervention/treatment
T3
Model SN60T3 assigned by AcrySof Toric calculator
Device: T3
Implantation of the AcrySof Toric Intraocular Lens (IOL) Model SN60T3

T4
Model SN60T4 assigned by AcrySof Toric calculator
Device: T4
Implantation of the AcrySof Toric Intraocular Lens (IOL) Model SN60T4

T5
Model SN60T5 assigned by AcrySof Toric calculator
Device: T5
Implantation of the AcrySof Toric Intraocular Lens (IOL) Model SN60T5




Primary Outcome Measures :
  1. Visual Acuity [ Time Frame: 1 day to 6 months ]

Secondary Outcome Measures :
  1. Postoperative refractive cylinder [ Time Frame: 1day to 6 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Study population chosen from physician's patients implanted with the AcrySof Toric intraocular lens (IOL)
Criteria

Inclusion Criteria:

  • Diagnosed with cataracts; has astigmatism falling in range of AcrySof Toric lens as assessed by the AcrySof Toric calculator

Exclusion Criteria:

  • Ocular comorbidities affecting visual outcome data,
  • Prior refractive surgery,
  • Irregular astigmatism

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01214863


Locations
United States, Texas
Alcon Call Center for Trial Locations
Fort Worth, Texas, United States, 76134
Sponsors and Collaborators
Alcon Research

Responsible Party: Alcon Research
ClinicalTrials.gov Identifier: NCT01214863     History of Changes
Other Study ID Numbers: M07-007
First Posted: October 5, 2010    Key Record Dates
Last Update Posted: October 1, 2012
Last Verified: October 2010

Keywords provided by Alcon Research:
Toric Intraocular Lens (IOL)

Additional relevant MeSH terms:
Cataract
Astigmatism
Lens Diseases
Eye Diseases
Refractive Errors